The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Hormone Replacement Therapy and Incidence of Alzheimer Disease in Older Women<SUBTITLE>The Cache County Study</SUBTITLE>
Abstract
CONTEXT: Previous studies have shown a sex-specific increased risk of Alzheimer disease (AD) in women older than 80 years. Basic neuroscience findings suggest that hormone replacement therapy (HRT) could reduce a woman's risk of AD. Epidemiologic findings on AD and HRT are mixed. OBJECTIVE: To examine the relationship between use of HRT and risk of AD among elderly women. DESIGN, SETTING, AND PARTICIPANTS: Prospective study of incident dementia among 1357 men (mean age, 73.2 years) and 1889 women (mean age, 74.5 years) residing in a single county in Utah. Participants were first assessed in 1995-1997, with follow-up conducted in 1998-2000. History of women's current and former use of HRT, as well as of calcium and multivitamin supplements, was ascertained at the initial contact. MAIN OUTCOME MEASURE: Diagnosis of incident AD. RESULTS: Thirty-five men (2.6%) and 88 women (4.7%) developed AD between the initial interview and time of the follow-up (3 years). Incidence among women increased after age 80 years and exceeded the risk among men of similar age (adjusted hazard ratio [HR], 2.11; 95% confidence interval [CI], 1.22-3.86). Women who used HRT had a reduced risk of AD (26 cases among 1066 women) compared with non-HRT users (58 cases among 800 women) (adjusted HR, 0.59; 95% CI, 0.36-0.96). Risk varied with duration of HRT use, so that a woman's sex-specific increase in risk disappeared entirely with more than 10 years of treatment (7 cases among 427 women). Adjusted HRs were 0.41 (95% CI, 0.17-0.86) for HRT users compared with nonusers and 0.77 (95% CI, 0.31-1.67) compared with men. No similar effect was seen with calcium or multivitamin use. Almost all of the HRT-related reduction in incidence reflected former use of HRT (9 cases among 490 women; adjusted HR, 0.33 [95% CI, 0.15-0.65]). There was no effect with current HRT use (17 cases among 576 women; adjusted HR, 1.08 [95% CI, 0.59-1.91]) unless duration of treatment exceeded 10 years (6 cases among 344 women; adjusted HR, 0.55 [95% CI, 0.21-1.23]). CONCLUSIONS: Prior HRT use is associated with reduced risk of AD, but there is no apparent benefit with current HRT use unless such use has exceeded 10 years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
(1987) · PubMed · Cited by 2,657
Event History Analysis : Regression for Longitudinal Event Data
Allison, P. D. (1984) · Cited by 1,711
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
Tang, M.-X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B., Andrews, H., & Mayeux, R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03356-9 · Cited by 1,647
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (2011) · Neurology · doi:10.1212/01.wnl.0000400650.92875.cf · Cited by 1,495
Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease
in 't Veld, B. A., Ruitenberg, A., Hofman, A., Launer, L. J., van Duijn, C. M., Stijnen, T., Breteler, M. M. B., & Stricker, B. H. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010178 · Cited by 1,196
Kawas, C., Resnick, S., Morrison, A., Brookmeyer, R., Corrada, M., Zonderman, A., Bacal, C., Lingle, D. D., & Metter, E. (1997) · Neurology · doi:10.1212/wnl.48.6.1517 · Cited by 966
Estrogen Deficiency and Risk of Alzheimer's Disease in Women
Paganini-Hill, A., & Henderson, V. W. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117244 · Cited by 853
Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies
Andersen, K., Launer, L. J., Dewey, M. E., Letenneur, L., Ott, A., Copeland, J. R. M., Dartigues, J.-F., Kragh–Sorensen, P., Baldereschi, M., Brayne, C., et al. (1999) · Neurology · doi:10.1212/wnl.53.9.1992 · Cited by 650
Henderson, V. W. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540210068014 · Cited by 590
Fratiglioni, L., Viitanen, M., von Strauss, E., Tontodonati, V., Herlitz, A., & Winblad, B. (1997) · Neurology · doi:10.1212/wnl.48.1.132 · Cited by 556
Estrogen for Alzheimer’s disease in women: Randomized, double-blind, placebo-controlled trial
Henderson, V. W., Paganini-Hill, A., Miller, B. L., Elble, R. J., Reyes, P. F., Shoupe, D., McCleary, C. A., Klein, R. A., Hake, A. M., & Farlow, M. R. (2000) · Neurology · doi:10.1212/wnl.54.2.295 · Cited by 550
Alzheimer's disease: A study of epidemiological aspects
Heyman, A., Wilkinson, W. E., Stafford, J. A., Helms, M. J., Sigmon, A. H., & Weinberg, T. (1984) · Annals of Neurology · doi:10.1002/ana.410150406 · Cited by 525
A case‐control study of Alzheimer's disease in Australia
Broe, G. A., Henderson, A. S., Creasey, H., McCusker, E., Korten, A. E., Jorm, A. F., Longley, W., & Anthony, J. C. (1990) · Neurology · doi:10.1212/wnl.40.11.1698 · Cited by 445
APOE -ε4 count predicts age when prevalence of AD increases, then declines: The Cache County Study
Breitner, J. C. S., Wyse, B. W., Anthony, J. C., Welsh-Bohmer, K. A., Steffens, D. C., Norton, M. C., Tschanz, J. T., Plassman, B. L., Meyer, M. R., Skoog, I., et al. (1999) · Neurology · doi:10.1212/wnl.53.2.321 · Cited by 397 · cited 1×
“Details of the study protocol have been published previously.(3,19) Briefly, between 1995-1997 we used a multistage screening and assessment protocol (wave I) to diagnose cases of dementia among 5677 elderly residents of Cache County, Utah.”
Self-citationAmaducci, L. A., Fratiglioni, L., Rocca, W. A., Fieschi, C., Livrea, P., Pedone, D., Bracco, L., Lippi, A., Gandolfo, C., Bino, G., et al. (1986) · Neurology · doi:10.1212/wnl.36.7.922 · Cited by 365
Incidence of AD may decline in the early 90s for men, later for women: The Cache County study
Miech, R. A., Breitner, J. C. S., Zandi, P. P., Khachaturian, A. S., Anthony, J. C., & Mayer, L. (2002) · Neurology · doi:10.1212/wnl.58.2.209 · Cited by 331
Self-citationThe Women’s Health Initiative Memory Study (WHIMS)
Shumaker, S. A., Reboussin, B. A., Espeland, M. A., Rapp, S. R., McBee, W. L., Dailey, M., Bowen, D., Terrell, T., & Jones, B. N. (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(98)00038-5 · Cited by 321
Brenner, D. E., Kukull, W. A., Stergachis, A., van Belle, G., Bowen, J. D., McCormick, W. C., Ten, L., & Larson, E. B. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117245 · Cited by 302
Postmenopausal estrogen replacement therapy and risk of AD: A population-based study
Waring, S. C., Rocca, W. A., Petersen, R. C., O’Brien, P. C., Tangalos, E. G., & Kokmen, E. (1999) · Neurology · doi:10.1212/wnl.52.5.965 · Cited by 293
Chance, development, and aging
de Grey, A. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00123-1 · Cited by 280
Finch, C. E., & Kirkwood, T. (2000) · doi:10.25405/ncl.34589739 · Cited by 268
Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging
Baldereschi, M., Di Carlo, A., Lepore, V., Bracco, L., Maggi, S., Grigoletto, F., Scarlato, G., Amaducci, L., & ILSA Working Group* (1998) · Neurology · doi:10.1212/wnl.50.4.996 · Cited by 257
A case‐control study of Alzheimer's disease
Graves, A. B., White, E., Koepsell, T. D., Reifler, B. V., Van Belle, G., Larson, E. B., & Raskind, M. (1990) · Annals of Neurology · doi:10.1002/ana.410280607 · Cited by 237
Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: The Cache County Study
Anthony, J. C., Breitner, J. C. S., Zandi, P. P., Meyer, M. R., Jurasova, I., Norton, M. C., & Stone, S. V. (2000) · Neurology · doi:10.1212/wnl.54.11.2066 · Cited by 224
Self-citationEstrogen Replacement Therapy and Cognitive Decline in Older Community Women
Matthews, K., Cauley, J., Yaffe, K., & Zmuda, J. M. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb02563.x · Cited by 208
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.10.1279 · Cited by 207
Postmenopausal Estrogen Replacement Therapy and the Risk of Alzheimer Disease
Seshadri, S. S., Zornberg, G. L., Derby, L. E., Myers, M. W., Jick, H., & Drachman, D. A. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.435 · Cited by 150
Lack of postmenopausal estrogen replacement therapy and the risk of dementia
Mortel, K. F., & Meyer, J. (1995) · Journal of Neuropsychiatry · doi:10.1176/jnp.7.3.334 · Cited by 145
Estrogen to treat Alzheimer’s disease: Too little, too late?
Marder, K. S., & Sano, M. (2000) · Neurology · doi:10.1212/wnl.54.11.2035 · Cited by 75
Cited by
Shumaker, S. A., Legault, C., Rapp, S. R., Thal, L., Wallace, R. B., Ockene, J. K., Hendrix, S. L., Jones III, B. N., Assaf, A. R., Jackson, R. D., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2651 · Cited by 2,178
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences
Mielke, M., Vemuri, P., & Rocca, W. (2014) · Clinical Epidemiology · doi:10.2147/clep.s37929 · Cited by 1,021
Metadata
- Authors
- Zandi, P. P.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2002-11-06
- Volume
- 288
- Issue
- 17
- Pages
- 2123
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2044241508
- Cited by
- 906
- References
- 30
- FWCI
- 36.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.